Cargando…
Breakthrough seizures—Further analysis of the Standard versus New Antiepileptic Drugs (SANAD) study
OBJECTIVES: To develop prognostic models for risk of a breakthrough seizure, risk of seizure recurrence after a breakthrough seizure, and likelihood of achieving 12-month remission following a breakthrough seizure. A breakthrough seizure is one that occurs following at least 12 months remission whil...
Autores principales: | Bonnett, Laura J., Powell, Graham A., Tudur Smith, Catrin, Marson, Anthony G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739445/ https://www.ncbi.nlm.nih.gov/pubmed/29267375 http://dx.doi.org/10.1371/journal.pone.0190035 |
Ejemplares similares
-
Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial
por: Bonnett, L J, et al.
Publicado: (2017) -
Treatment outcome after failure of a first antiepileptic drug
por: Bonnett, Laura J., et al.
Publicado: (2014) -
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II)
por: Balabanova, Silviya, et al.
Publicado: (2020) -
Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs
por: Bonnett, Laura J., et al.
Publicado: (2020) -
Risk of recurrence after a first seizure and implications for driving: further analysis of the Multicentre study of early Epilepsy and Single Seizures
por: Bonnett, L J, et al.
Publicado: (2010)